Could eating whey protein before meals help reduce blood sugar spikes?
From full-fat milk to probiotic yogurt and whey protein, researchers examine whether what we consume, how it is…
A New King of The GLP-1s Could Be Crowned – Cardiac Wire
A New King of The GLP-1s Could Be Crowned Cardiac Wire‘Godzilla’ of weight-loss drugs could provide other important health…
GLP-1 receptor agonist exposure shows no link to major adverse pregnancy outcomes
New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes…
Digital companion apps help secure long-term habits during GLP-1 therapy
Glucagon-like peptide-1 (GLP-1) medications have revolutionized weight management, yet high dropout rates and rapid weight regain remain significant…
GLP-1 drugs appear psychiatrically safe, but one finding still raises questions
With millions of patients now taking GLP-1 drugs, researchers examined whether concerns about depression and suicidality are supported…
Semaglutide extended lifespan in older female mice, but that was not the only finding
A late-life experiment reveals how a widely used metabolic drug reshapes age-related physiology and molecular pathways, with effects…
New review highlights FOXA2’s role in glucose regulation pathways
A newly published review highlights the pivotal role of FOXA2, a key transcription factor, in coordinating pancreatic development,…
Ten-million-person study links semaglutide to lower COVID-19 mortality
After accounting for major health differences between semaglutide users and non-users, researchers identified a striking mortality association that…
Semaglutide and tirzepatide linked to fewer alcohol-related hospital visits
A large US health-record study suggests newer GLP-1 drugs may reduce alcohol-related acute-care visits, but the findings remain…
GLP-1 receptor activation linked to lower depression and bipolar disorder odds
Lifelong genetic differences associated with GLP-1 receptor activity point to possible mental health benefits beyond weight and glucose…
Semaglutide dose may matter more than weight loss for heart health
A large real-world study suggests semaglutide’s cardiovascular benefits may be more closely linked to the dose patients receive…
Nearly one in 10 Britons use or want weight-loss medication
A nationally representative survey estimates that millions of adults in Great Britain have already used GLP-1-based weight-loss medicines…